Increasing Natural Killer Cell Activity in Pancreatic Cancer
Promoting Activated Natural Killer (NK) Cell Accumulation in Pancreatic Cancer
This study is looking at ways to make your body's natural killer cells work better against pancreatic cancer, with the hope of improving treatment options and outcomes for patients like you.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Georgetown University NIH-funded |
| Lab location | 1 site (Washington, United States) |
| Project ID | NIH-10995994 on NIH RePORTER |
What this research studies
This research investigates how to enhance the activity of natural killer (NK) cells in pancreatic cancer, a type of cancer known for its poor survival rates. The study focuses on the tumor microenvironment and aims to promote the co-localization of activated NK cells with cancer cells to improve anti-tumor responses. By using a specific inhibitor that targets enzymes involved in cancer progression, the research seeks to boost the effectiveness of existing immunotherapy treatments. Patients may benefit from new therapeutic strategies that could improve outcomes in pancreatic cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with pancreatic ductal adenocarcinoma who are seeking innovative treatment options.
Not a fit: Patients with other types of cancer or those who are not diagnosed with pancreatic cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for pancreatic cancer, potentially improving survival rates.
How similar studies have performed: Previous research has shown promising results in enhancing NK cell activity in other cancers, suggesting potential success for this novel approach in pancreatic cancer.
Where this research is happening
Washington, United States
- Georgetown University — Washington, United States (Active)
Researchers
- Principal investigator: Lekan, Alexander — Georgetown University
- Study coordinator: Lekan, Alexander
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.